DK1572217T3 - Kombinationsmedikament af R,R-formoterol og ciclesonid - Google Patents

Kombinationsmedikament af R,R-formoterol og ciclesonid

Info

Publication number
DK1572217T3
DK1572217T3 DK03789217T DK03789217T DK1572217T3 DK 1572217 T3 DK1572217 T3 DK 1572217T3 DK 03789217 T DK03789217 T DK 03789217T DK 03789217 T DK03789217 T DK 03789217T DK 1572217 T3 DK1572217 T3 DK 1572217T3
Authority
DK
Denmark
Prior art keywords
ciclesonide
formoterol
combination drug
salt
combination
Prior art date
Application number
DK03789217T
Other languages
English (en)
Inventor
Klaus Dietzel
Degenhard Marx
Helgert Mueller
Christian Weimar
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of DK1572217T3 publication Critical patent/DK1572217T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
DK03789217T 2002-12-12 2003-12-11 Kombinationsmedikament af R,R-formoterol og ciclesonid DK1572217T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027797 2002-12-12
DE10306213 2003-02-13
PCT/EP2003/014045 WO2004052374A1 (en) 2002-12-12 2003-12-11 Combination medicament

Publications (1)

Publication Number Publication Date
DK1572217T3 true DK1572217T3 (da) 2008-12-15

Family

ID=32509778

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03789217T DK1572217T3 (da) 2002-12-12 2003-12-11 Kombinationsmedikament af R,R-formoterol og ciclesonid

Country Status (15)

Country Link
US (2) US7879833B2 (da)
EP (1) EP1572217B1 (da)
JP (1) JP4755495B2 (da)
AT (1) ATE405275T1 (da)
AU (1) AU2003293833B2 (da)
CA (1) CA2508692C (da)
DE (1) DE60323138D1 (da)
DK (1) DK1572217T3 (da)
ES (1) ES2312844T3 (da)
HR (1) HRP20050611B1 (da)
IS (1) IS2597B (da)
PL (1) PL375819A1 (da)
PT (1) PT1572217E (da)
RS (1) RS51707B (da)
WO (1) WO2004052374A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8025896B2 (en) 2001-07-16 2011-09-27 Depuy Products, Inc. Porous extracellular matrix scaffold and method
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
WO2004110460A1 (en) 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
AU2004271744B2 (en) 2003-09-16 2010-07-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
EP1796679A1 (en) * 2004-09-10 2007-06-20 Altana Pharma AG Ciclesonide and syk inhibitor combination and methods of use thereof
WO2011093814A2 (en) * 2010-01-29 2011-08-04 Mahmut Bilgic A pharmaceutical combination comprising formoterol and ciclesonide
KR20140025308A (ko) * 2010-10-12 2014-03-04 시플라 리미티드 약학 조성물

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166396D1 (en) * 1980-02-27 1984-11-08 Tate & Lyle Plc Crystalline glucose and process for its production
US4816445A (en) * 1984-06-21 1989-03-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Crystalline alpha-maltose
JP2518646B2 (ja) * 1987-05-29 1996-07-24 株式会社 林原生物化学研究所 マルト−ス粉末の製造方法
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DK0407028T4 (da) 1989-05-31 2000-01-31 Fisons Plc Anordning til inhalation af medikamenter og sammensætning af medikamenter
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
ATE92762T1 (de) 1989-09-08 1993-08-15 Glaxo Group Ltd Medikamente.
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
US5178866A (en) * 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
JPH06502391A (ja) * 1990-07-26 1994-03-17 ジー.ディー.サール アンド カンパニー ポリマー性薬剤送達システム
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
US5434304A (en) * 1990-09-26 1995-07-18 Aktiebolaget Astra Process for preparing formoterol and related compounds
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US6866839B2 (en) * 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5474759A (en) * 1991-06-10 1995-12-12 Schering Corporation Non-chlorofluorocarbon aerosol formulations
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
HU0004452D0 (da) 1991-12-18 2001-01-29 Astra Ab
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
CN1062869C (zh) * 1993-04-02 2001-03-07 比克·古尔顿·劳姆贝尔格化学公司 新型脱氢皮质醇衍生物
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of drug patramulations
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
AU6111796A (en) * 1995-06-12 1997-01-09 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5 -lipoxygenase inhibitor
US5840917A (en) * 1995-09-26 1998-11-24 Takeda Chemical Industries, Ltd. Phosphorylamides, their preparation and use
DE19635498A1 (de) 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
SE9603725D0 (sv) 1996-10-11 1996-10-11 Astra Ab New teatment
US6599927B2 (en) * 1996-10-11 2003-07-29 Astrazeneca Ab Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome
FR2754712B1 (fr) * 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US6613795B2 (en) * 1996-11-11 2003-09-02 Christian Noe Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
DK0938467T3 (da) 1996-11-11 2002-10-07 Sepracor Inc Fremgangsmåde til fremstilling af optisk rene isomerer af formoterol
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB2329939A (en) * 1997-06-26 1999-04-07 Glaxo Group Ltd Self-lubricating valve stem for aerosol containers
US6470894B2 (en) 1997-09-19 2002-10-29 Thione International, Inc. Glutathione, green tea, grape seed extract to neutralize tobacco free radicals
KR20010024453A (ko) 1997-10-08 2001-03-26 더글라스이.리디치 에어로졸 투여용 투약 형태
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
AU1507199A (en) * 1997-12-15 1999-07-05 Yamanouchi Pharmaceutical Co., Ltd. Novel pyrimidine-5-carboxamide derivatives
SE9801368D0 (sv) 1998-04-20 1998-04-20 Astra Ab New use
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
ATE283033T1 (de) * 1998-07-24 2004-12-15 Jago Res Ag Medizinische aerosolformulierungen
CA2338680C (en) * 1998-08-04 2008-10-14 Jago Research Ag Medicinal aerosol formulations
NZ510610A (en) 1998-09-23 2003-07-25 Altana Pharma Ag Tetrahydropyridoethers
RU2221552C2 (ru) * 1998-11-13 2004-01-20 Джаго Рисерч Аг Сухой порошок для ингаляции
US6352152B1 (en) 1998-12-18 2002-03-05 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6124268A (en) * 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
JP2001048807A (ja) 1999-08-04 2001-02-20 Wakamoto Pharmaceut Co Ltd 難溶性薬物を水に溶解してなる製剤
DE19947234A1 (de) 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
GB0002336D0 (en) 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
GB0009607D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0015043D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
FI20002177A0 (fi) 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6528527B2 (en) * 2000-11-07 2003-03-04 Merck & Co., Inc. Method of treatment with a combination of a PDE4 inhibitor and a leukotriene antagonist
KR100881258B1 (ko) * 2000-12-22 2009-02-05 글락소 그룹 리미티드 살메테롤 지나포에이트를 위한 정량식 흡입기
ATE369121T1 (de) * 2001-02-06 2007-08-15 Innovata Biomed Ltd Bimodale trockenpulverzusammensetzung zur inhalation
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
WO2003006310A1 (fr) 2001-07-13 2003-01-23 Tfe Techniques Et Fabrications Electroniques Dispositif destine a indiquer acoustiquement a un plongeur equipe d'un scaphandre la pression de gaz de respiration dans le reservoir et/ou la pression hydrostatique
EP1438019A1 (en) * 2001-10-24 2004-07-21 PARI GmbH Spezialisten für effektive Inhalation Kit for the preparation of a pharmaceutical composition
AU2002339163B2 (en) 2001-11-17 2008-07-03 Aventis Pharma Limited Pharmaceutical product with an adsorbent
AU2002342917A1 (en) * 2001-11-19 2003-06-10 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
ITMI20020808A1 (it) * 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
EP3513813A1 (en) * 2002-07-02 2019-07-24 Astrazeneca Ciclesonide-containing sterile aqueous suspension
DK1545548T3 (da) * 2002-08-30 2010-09-27 Nycomed Gmbh Anvendelsen af kombinationen af ciclesonid og antihistaminer til behandingen af allergisk rhinitis
CA2525943A1 (en) 2003-05-22 2004-12-02 Altana Pharma Ag Salmeterol and ciclesonide combination
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
WO2004110460A1 (en) 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
AU2004271744B2 (en) * 2003-09-16 2010-07-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases

Also Published As

Publication number Publication date
JP4755495B2 (ja) 2011-08-24
IS2597B (is) 2010-03-15
EP1572217B1 (en) 2008-08-20
CA2508692A1 (en) 2004-06-24
HRP20050611A2 (en) 2006-09-30
US7879833B2 (en) 2011-02-01
HRP20050611B1 (hr) 2013-12-20
US20060025392A1 (en) 2006-02-02
CA2508692C (en) 2012-04-03
EP1572217A1 (en) 2005-09-14
AU2003293833B2 (en) 2009-10-01
US20110086827A1 (en) 2011-04-14
WO2004052374A1 (en) 2004-06-24
US8258124B2 (en) 2012-09-04
ES2312844T3 (es) 2009-03-01
JP2006514686A (ja) 2006-05-11
RS20050429A (en) 2007-12-31
ATE405275T1 (de) 2008-09-15
RS51707B (sr) 2011-10-31
PT1572217E (pt) 2008-11-28
AU2003293833A1 (en) 2004-06-30
IS7910A (is) 2005-06-23
PL375819A1 (en) 2005-12-12
DE60323138D1 (de) 2008-10-02

Similar Documents

Publication Publication Date Title
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
ATE461217T1 (de) Glp-1-verbindungen
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
NL1025404A1 (nl) Pyrazolo-triazine verbindingen en gebruik daarvan.
DK1534277T3 (da) Acylerede, heteroaryl-kondenserede cycloalkenylaminer og anvendelse af disse som lægemidler
IS2597B (is) Lyf samsett úr R,R-formóteróli og siklesóníði
CY1108808T1 (el) Ενωσεις μοτιλιδης
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
DK1611884T3 (da) Plaster, indeholdende diclofenac
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
DK2845594T3 (da) Anvendelse af dihydroimidazoloner til behandlingen af hunde.
NO20061944L (no) Ny assosiasjon av et antiaterotrombotisk middel og et antiplateaggregerede middel
DE60319388D1 (de) C6- UND C9-SUBSTITUIERTE CHROMENOÄ4,3-cÜISOXAZOLIN
NO20050781L (no) Cefalosporiner
EA200501088A1 (ru) Цетилпиридиниевая соль противоспалительного средства и фармацевтические композиции, содержащие ее
BRPI0410638A (pt) derivados de azitromicina
TW200510461A (en) Disialoundecaglycosylasparagine - fatty acid amide and medicine containing the same
DK1592417T3 (da) Kombinationen af antidiabetiske lægemidler
PT1358182E (pt) Derivados de diazocinas e sua utilizacao como inibidores de triptase
RU2002117643A (ru) Люплатекс, обладающий противолучевыми свойствами
FI20021817A0 (fi) Kanyyli
ITRM20030440A0 (it) Sistema d'indicazione temporale, in particolare dell'orario.
RU2003103889A (ru) Антигипоксический препарат
ITPD20030307A1 (it) Slamatore con bloccaggio dell'amo
ES1053443Y (es) Pijama perfeccionado.